KalVista Pharma Stock (NASDAQ:KALV), Quotes and News Summary

Q: What sector and industry does KalVista Pharma (KALV) operate in?

KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.

Open	$12.240
Close	$12.130
Volume / Avg.	199.657K / 785.701K
Day Range	11.955 - 12.480
52 Wk Range	7.210 - 16.880
Market Cap	$511.744M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	13.81%
Days to Cover	9.14

Recent News

Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

What's Going With Hereditary Angioedema-Focused KalVista Pharmaceuticals Stock On Tuesday?

Results from KalVista Pharmaceuticals' Phase 3 KONFIDENT trial. Sebetralstat, an oral on-demand therapy, shows efficacy for hereditary angioedema.

Vandana Singh

Insiders Buying Monro And 3 Other Stocks

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy KalVista Pharma (KALV) stock?

You can purchase shares of KalVista Pharma (NASDAQ: KALV) through any online brokerage.

View our list of the best stock brokerages.

Who are KalVista Pharma's (KALV) competitors?

Other companies in KalVista Pharma’s space includes: Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).

What is the target price for KalVista Pharma (KALV) stock?

The latest price target for KalVista Pharma (NASDAQ: KALV) was reported by HC Wainwright & Co. on Friday, May 3, 2024. The analyst firm set a price target for 20.00 expecting KALV to rise to within 12 months (a possible 64.88% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for KalVista Pharma (KALV)?

The stock price for KalVista Pharma (NASDAQ: KALV) is $12.13 last updated May 3, 2024 at 4:00 PM EDT.

Does KalVista Pharma (KALV) pay a dividend?

There are no upcoming dividends for KalVista Pharma.

When is KalVista Pharma (NASDAQ:KALV) reporting earnings?

KalVista Pharma’s Q4 earnings are confirmed for Friday, July 5, 2024.

Is KalVista Pharma (KALV) going to split?

There is no upcoming split for KalVista Pharma.

What sector and industry does KalVista Pharma (KALV) operate in?

KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-